- Home
- STRO vs AIP Comparison
STRO vs AIP Comparison
Compare STRO & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- AIP
- Stock Information
- Founded
- STRO 2003
- AIP 2003
- Country
- STRO United States
- AIP United States
- Employees
- STRO N/A
- AIP N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- AIP Semiconductors
- Sector
- STRO Health Care
- AIP Technology
- Exchange
- STRO Nasdaq
- AIP Nasdaq
- Market Cap
- STRO 77.7M
- AIP 336.2M
- IPO Year
- STRO 2018
- AIP 2021
- Fundamental
- Price
- STRO $0.76
- AIP $9.23
- Analyst Decision
- STRO Hold
- AIP Strong Buy
- Analyst Count
- STRO 7
- AIP 3
- Target Price
- STRO $3.97
- AIP $15.00
- AVG Volume (30 Days)
- STRO 1.4M
- AIP 648.8K
- Earning Date
- STRO 08-12-2025
- AIP 07-31-2025
- Dividend Yield
- STRO N/A
- AIP N/A
- EPS Growth
- STRO N/A
- AIP N/A
- EPS
- STRO N/A
- AIP N/A
- Revenue
- STRO $66,434,000.00
- AIP $61,309,000.00
- Revenue This Year
- STRO N/A
- AIP $19.82
- Revenue Next Year
- STRO N/A
- AIP $17.29
- P/E Ratio
- STRO N/A
- AIP N/A
- Revenue Growth
- STRO N/A
- AIP 14.68
- 52 Week Low
- STRO $0.52
- AIP $5.46
- 52 Week High
- STRO $5.17
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- STRO 44.92
- AIP 60.06
- Support Level
- STRO $0.67
- AIP $8.66
- Resistance Level
- STRO $0.79
- AIP $10.11
- Average True Range (ATR)
- STRO 0.07
- AIP 0.69
- MACD
- STRO -0.01
- AIP 0.01
- Stochastic Oscillator
- STRO 34.52
- AIP 59.82
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.